Pharmagreen Biotech Inc (PK) (PHBI) 시세

https://x.com/pharmagreeninc/status/1884661136328438214

quiet board. loaded here at 002 company says updates coming, thin

She is running again...

Just curious, did you just graduate from a Laws of Attraction and Manifestation course at the Lotus Flower Academy in Butterfliesarefree, California or did you have a dream about fundamentals that just seemed so real?😏

Going to trips.

'I’ve also been mindful of saving on health expenses. Canadian pharmacy has been a reliable option for affordable medications and supplements, which helps free up more budget for other things—like exploring stock opportunities'....lol hahaha! a clickbait epic fail. How weak and silly.

How to Get a Cannabis License in Germany
There are three current companies contracted to produce cannabis for Germany. Those are Canadian firms Aphria and Aurora, and German company Demecan. They are allowed to produce three types of cannabis:

Type 1: 18% to 22% THC with less than 1% CBD
Type 2: 12% to 16% THC with less than 1% CBD
Type 3: 5% to 9% THC with 5% to 9% CBD

You may be surprised to learn that Germany does not issue actual cannabis cultivation licenses. Instead, they work through a system of contracts. The Cannabis Agency is a division of the BfArM department of Special Therapies and Traditional Medicines. Here is an overview of their contracting process:

BfArM holds a Europe-wide “public tendering process” (contract bidding)
BfArM issues “delivery contracts” for limited quantities and periods of time
The Cannabis Agency of BfArM purchases the cannabis, it cannot have excess amounts
The Cannabis Agency sells and distributes the cannabis; the Federal Opium Agency oversees cannabis importation
Until the next bidding opportunity, only the previously selected contractors can cultivate or manufacture cannabis
You need to meet many requirements to bid on German cannabis contracts. Below is a summary of what the German Cannabis Agency is looking for in contractors.

Cannabis Contract Bidding Requirements
Applicants cannot subcontract
Applicants must provide documentation to show that they are qualified to manufacture cannabis and that they have sufficient security
Applicants must have authorization to manufacture medicinal products under sec. 13 of the German Medicinal Products Act (AMG) and have a license for handling narcotic drugs
Applicants must be authorized to use the land where their site is located
The Cannabis Agency considers the applicant’s industry knowledge and professional experience, as evidenced by its suitability and contract requirements.
If approved, the applicant must follow requirements for safety measures (sec. 15 BtMG), record keeping (sec. 17 BtMG), and notifications to authorities (sec. 18 BtMG) in addition to GACP, EU-GMP, and specified monographs.
https://groweriq.ca/how-to-get-a-cannabis-license-in-germany/

Has anyone noticed the recent activity with Pharmagreen Biotech? The stock seems to be gaining attention lately—curious if anyone here has insights or is planning to invest. Speaking of investments, I’ve also been mindful of saving on health expenses. Canadian pharmacy has been a reliable option for affordable medications and supplements, which helps free up more budget for other things—like exploring stock opportunities

Anybody here ever get an AGM notification or proxy materials?
https://stockhouse.com/companies/bullboard?symbol=phbi&threadid=36327794

Very 'interesting' and thankfully some honest reporting about the lay of the land... looks like the same individual that wrote the script for that forgettable misleading video last month is also writing the press releases.... “While these revenue projections are grounded in extensive market research and current industry conditions" really?...somebody needs to get fired ASAP....just who is driving the PHBI bus anyway?? Caveat emptor. https://stockhouse.com/companies/bullboard?symbol=phbi&threadid=36316223

Slap 0.0029 and get us to $0.003+

"The first step is to establish that something is possible; then probability will occur" Elon Musk

OUCH...CLOWN

Yes. Thinking of adding a bit more

Ready to push to $0.003ss

You stil in?

News sends PHBI $0.005+

Up 25%! Where is everyone?

I scooped up 0.0018sss. Finally, I'm in PHBI. 😁

Tanking.

I Took the 333K .0021s, then it dropps to .0019 

What's happening here?

Your 'old video' reply seems to be just disinfo-shade and now crickets. The video was posted on Youtube on October 8th, 2024 by
Zoggen360 Marketing and on X by a shareholder on October 16th. It is also not archived on the company's Youtube channel nor in the company website video section. In the video at the 2:50 mark it states that the CEO ‘has recently involved himself in on-line question and answer periods with investors…” with the first pne being October 7th . At the 2:23 mark the ceo’s ‘leadership is characterised ,,,,,,and a commitment to transparency’.
At the 2:28 mark ‘Pharmagreen has not only established itself as a leader in the cannabis industry…”. In what sector and by what metric(s)?
https://companiesmarketcap.com/eur/cannabis/largest-cannabis-companies-by-market-cap/
https://tracxn.com/d/trending-business-models/startups-in-cannabis-research-services/__bMKXdvu-83JlL7zrvYsJUPMAICFSyHckxwrpn66BKs8/companies
https://www.greenhousegrower.com/crops/cannabis/cannabis-top-20-north-americas-largest-commercial-grows/
https://biopharmguy.com/links/company-by-location-cannabis.php

At the 5:32 mark ‘For investors seeking a profitable company …Pharmagreen biotech inc deserves attention’. Since when did PHBI become a profitable company?
At the 5:51 mark the narrator states that 'as of the 2nd of October 2024 ...has a market cap of...and as of the same date it has 666xxxxxx shares outstanding…”
At the 6:26 mark ”….we trust you have enjoyed this informative video on Pharmagreen Biotech Inc traded on the OTCQB market’.


From the ‘ABOUT’ section at the PHBI website: “Pharmagreen Biotech Inc. (OTCQB: PHBI) is building a vertically…”
I rest my case.

Who gave you that information?

That’s an old video

As they say, 'the devil is in the details'. Why would management put out a commercial on youtube that states in the video title "PharmaGreen Biotec Inc. Infomercial (OTCQB:PHBI)", and in the intro-text: "PharmaGreen Biotech Inc. is an upcoming medicinal marijuana company based in California. The stock trades on the OTCQB under the symbol PHBI" and the same is stated in the video when obviously it does not trade on the QB? Also does anyone know if any of those images used in the video are truly actually representative of the operations/physical plant in California? If they are not, when added to the 'QB' misrepresentation (which is also stated on the company's X page) it is false and by base-line industry standards unacceptably misleading. How does that help?

Eh another pot stock. Garbage.

How can something with no value (at present) be under valued? Unless you consider that worn out, tired, abused and misused element from the bottom of the pubic market periodic table called 'promotium' of value, The 'news' was just a rewrite regurgitation of the last podcast on X.

Today's volume 7.1M, above average

Fairly solid accumulation today.

nice

Volume exploding.

We are nearly 1/2 way to a penny.

Added a few more.

Let’s ride.

Seeing copper here.

I guess you forgot to read what it’s contingent on

This is very seriously undervalued.

News out is excellent.

This can jump 500 percent from here in the very near term.

Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project
09:15:00 AM ET, 10/10/2024 - GlobeNewswire

CARSON CITY, Nev., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is thrilled to highlight the significant revenue potential from its latest project under development. During a special session on Creative Spaces, hosted on X on Monday, October 7, 2024, CEO Peter Wojcik shared exciting insights into the company's business advancements and growth strategies.

Pharmagreen is developing a specialized form of cannabis oil known as Live Rosin, a highly sought-after cannabis concentrate recognized for its unmatched purity, potency, and rich flavor profile. Produced through a solventless extraction process that uses no chemical solvents, Live Rosin sets a new standard for quality in the cannabis industry. Pharmagreen’s proprietary extraction technique ensures the highest cannabinoid recovery rates, while maintaining the plant’s natural properties. This process is further enhanced by the company’s exclusive Standard Organic Non-Spray Cultivation Procedures (SONSCP), ensuring the optimal cultivation and quality of their crops.

Pharmagreen’s innovative farming and processing model is designed to yield an average of 6,000 liters of Live Rosin per 100-acre farm, per crop cycle, depending on the cannabinoid content of the plants. With 4 to 5 crop cycles per year, depending on the strain, the company is poised for significant production output. Live Rosin currently commands retail prices ranging from $40 to $100 per gram in the U.S., with even higher prices in European markets.

Pharmagreen’s projected revenues are impressive:

At $1 per gram, estimated gross revenues are $19 million in year 1, rising to $32 million by year 3.
At $5 per gram, revenues are projected to reach $95 million in year 1 and $158 million by year 3.
At $10 per gram, revenues could soar to $190 million in year 1, growing to $317 million by year 3.
At $20 per gram, revenue estimates reach $381 million in year 1, and a staggering $635 million by year 3.

To ensure successful distribution and market access for its premium Live Rosin, Pharmagreen is actively seeking distributors, joint venture partnerships, and is exploring the acquisition of a cGMP-certified cannabis lab in Europe. This strategic move would enable Pharmagreen to tap into the lucrative EU cannabis market, where Live Rosin commands even higher prices.

While these revenue projections are grounded in extensive market research and current industry conditions, they are dependent on the successful completion of several key milestones. These include securing cannabis production and processing licenses, export/import permits from foreign governments, land leases, and the necessary funding to establish the cannabis farm and processing facility, as well as ensuring market access for product sales. Pharmagreen is making consistent progress toward these critical objectives, though outcomes cannot be guaranteed at this stage.

Peter Wojcik, CEO of Pharmagreen Biotech Inc., stated, "The revenue projections are indeed promising, and I am eager to bring them to fruition once the initial milestones are achieved. This is an exciting project, and it’s a privilege to be leading its development."

If anyone here has level 2 market access, (I don't and don't need/want a subscription). I am wondering if 'you' wouldn't mind posting the individual trades of PHBI shares from September 10th to the close of the market on September 19th, or a page link to same, and hopefully that would include the name or number of the B/D buyers and sellers. Doing some basic DD. Any assistance is greatly appreciated, Thanks

What news are they talking about?

News perhaps

@pharmagreeninc
Pharmagreen Biotech Inc. (OTC PINK: $PHBI) is pleased to announce that it will be releasing its news release this week, as previously communicated. Pharmagreen remains committed to transparency and keeping stakeholders informed as it continues to advance business development.
6:45 AM · Oct 9, 2024
·
3,145
Views

is there actual news, or is this hype?

You ever get your money back from BHUB? I am still waiting.

This board is quiet.

Holding its gains pretty good.

I see some people excited about this on Twitter or X, do they have any money? do they have any financials? from what I can find is they pretty much have nothing but that's from like a year ago

Nice close here

Looking good $PHBI

on sale

Bought a few here

wild

churn